BlackRock Amends MACROGENICS Stake, Maintains Passive Position
Ticker: MGNX · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1125345
| Field | Detail |
|---|---|
| Company | Macrogenics INC (MGNX) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still owns a big chunk of MACROGENICS, signaling stability.**
AI Summary
BlackRock, Inc. filed an amended Schedule 13G/A on January 24, 2024, disclosing its ownership in MACROGENICS INC as of December 31, 2023. This amendment, the 9th for this holding, indicates that BlackRock continues to hold a significant passive stake in the pharmaceutical company. For investors, this filing confirms that a major institutional investor like BlackRock maintains its position, which can be seen as a vote of confidence in MACROGENICS INC's long-term prospects, potentially influencing other investors' decisions.
Why It Matters
This filing shows BlackRock, a major institutional investor, still holds a significant stake in MACROGENICS INC, signaling continued confidence in the company's future.
Risk Assessment
Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate new risks or significant changes in strategy.
Analyst Insight
An investor should note that BlackRock's continued passive stake suggests stability, but this filing alone doesn't provide new information for a buy/sell decision. It's a routine update, not a change in investment thesis.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person and institutional investor
- MACROGENICS INC (company) — the subject company in which BlackRock holds shares
- December 31, 2023 (date) — the date of the event requiring this filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No. 9, as stated in the filing.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as clearly identified in the 'Names of reporting persons' section of the filing.
What is the subject company of this filing?
The subject company is MACROGENICS INC, as indicated in the 'Name of Issuer' section of the Schedule 13G.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing.
Under which rule was this Schedule 13G/A filed?
This Schedule 13G/A was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding MACROGENICS INC (MGNX).